(0.11%) 5 254.35 points
(0.12%) 39 807 points
(-0.12%) 16 379 points
(2.16%) $83.11
(1.98%) $1.752
(1.90%) $2 254.80
(1.41%) $25.10
(1.45%) $922.85
(0.38%) $0.927
(0.71%) $10.84
(0.14%) $0.792
(0.14%) $92.57
Live Chart Being Loaded With Signals
Cassiopea S.p.A., a clinical-stage specialty pharmaceutical company, focuses on developing and commercializing medical dermatology products worldwide. It offers Winlevi, an antiandrogen, which has completed Phase III clinical trial for the topical treatment of acne; Breezula, a topical antiandrogen that is in Phase II clinical trial to treat androgenic alopecia; CB-06-01, a topical antibiotic, which is in Phase II clinical trial for the treatment of acne, including strains resistant to other antibiotics; and CB-06-02, a novel integrin activator that has completed Phase II clinical trial to treat genital warts...
Stats | |
---|---|
Today's Volume | 2 756.00 |
Average Volume | 1 818.00 |
Market Cap | 0.00 |
Last Dividend | CHF0 ( N/A ) |
Next Dividend | CHF0 ( N/A ) |
P/E | -28.13 |
ATR14 | CHF0 (0.00%) |
Cassiopea SpA Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Cassiopea SpA Financials
Annual | 2020 |
Revenue: | CHF0.00 |
Gross Profit: | CHF-611 000 (0.00 %) |
EPS: | CHF-1.183 |
Q2 | 2020 |
Revenue: | CHF0.00 |
Gross Profit: | CHF-317 000 (0.00 %) |
EPS: | CHF-0.320 |
Q1 | 2020 |
Revenue: | CHF0.00 |
Gross Profit: | CHF0.00 (0.00 %) |
EPS: | CHF-0.212 |
Q2 | 2019 |
Revenue: | CHF0.00 |
Gross Profit: | CHF0.00 (0.00 %) |
EPS: | CHF-0.283 |
Financial Reports:
No articles found.
Cassiopea SpA
Cassiopea S.p.A., a clinical-stage specialty pharmaceutical company, focuses on developing and commercializing medical dermatology products worldwide. It offers Winlevi, an antiandrogen, which has completed Phase III clinical trial for the topical treatment of acne; Breezula, a topical antiandrogen that is in Phase II clinical trial to treat androgenic alopecia; CB-06-01, a topical antibiotic, which is in Phase II clinical trial for the treatment of acne, including strains resistant to other antibiotics; and CB-06-02, a novel integrin activator that has completed Phase II clinical trial to treat genital warts. The company was formerly known as Cosmo Dermatos S.r.l. Cassiopea S.p.A. was founded in 2013 and is based in Lainate, Italy. As of December 2, 2021, Cassiopea S.p.A. operates as a subsidiary of Cosmo Pharmaceuticals N.V.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators